Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Transgenrx
AddedFeb 15, 2024
UpdatedJun 18, 2026
Transgenrx

Transgenrx

TransGenRx: Innovating biopharmaceutical manufacturing with cost-effective, custom protein-based drug production.

HQ
Baton Rouge, LA, US
Founded
2002
Overview
Compare
Fundraising
Employees

TransGenRx is a biopharmaceutical manufacturing company focused on reducing the cost of producing protein-based drugs. Utilizing a high-expressing avian cell line and a patented vector system, TransGenRx develops custom proteins to meet diverse specifications, aiming to revolutionize the biopharmaceutical industry with their innovative technology.

TransGenRx has achieved significant advancements in biopharmaceutical manufacturing, leveraging patented and patent-pending processes to deliver cost-effective solutions. Their impact is evident in the development of custom proteins that cater to a wide range of needs, positioning them as a key player in the industry.

Transgenrx - Similar Companies

Transposagen Biopharmaceuticals logo

Transposagen Biopharmaceuticals

RegeneRx Biopharmaceuticals logo

RegeneRx Biopharmaceuticals

Celltheon logo

Celltheon

celltheon.com

Origen Therapeutics logo

Origen Therapeutics

ExpressCells logo

ExpressCells

Sunflower Therapeutics logo

Sunflower Therapeutics

sunflowertx.com

Rbio logo

Rbio

rbio.online

Chlorogen logo

Chlorogen

chlorogen.com

Sinogen Biopharma logo

Sinogen Biopharma

GeneBiology logo

GeneBiology

RoosterBio logo

RoosterBio

BridGene Biosciences logo

BridGene Biosciences

Regenxbio logo

Regenxbio

regenxbio.com

Transpire Bio logo

Transpire Bio

transpirebio.com

Repligen logo

Repligen

repligen.com

Transgenrx - Quick Facts

Who are Transgenrx's competitors?

Companies similar to Transgenrx include Transposagen Biopharmaceuticals, RegeneRx Biopharmaceuticals, Celltheon and Origen Therapeutics.

When was Transgenrx founded?

Transgenrx was founded in 2002.

Where is Transgenrx's headquarters located?

Transgenrx's headquarters is located in Baton Rouge, LA, US.

When was Transgenrx's last funding round?

Transgenrx's most recent funding round was for $6.5M (USD) in October 2010.

How much has Transgenrx raised to-date?

As of Oct 14, 2010, Transgenrx has raised a total of $6.9M (USD).

How many employees does Transgenrx have?

Transgenrx has 7 employees as of Feb 5, 2024.

Transgenrx - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Licensing
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Drug Development
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 20 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 440000Retail Trade
  • 449000Furniture, Home Furnishings, Electronics, and Appliance Retailers
  • 449200Electronics and Appliance Retailers
  • 449210Electronics and Appliance Retailers
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 5700Home Furniture, Furnishings, And Equipment Stores
  • 8000Health Services
  • 2830Drugs
  • 5730Radio, Television, Consumer Electronics, And Music Stores
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 5734Computer And Computer Software Stores
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified